DE102006011922A1 - Mittel zur Behandlung von Tinnitus - Google Patents

Mittel zur Behandlung von Tinnitus Download PDF

Info

Publication number
DE102006011922A1
DE102006011922A1 DE102006011922A DE102006011922A DE102006011922A1 DE 102006011922 A1 DE102006011922 A1 DE 102006011922A1 DE 102006011922 A DE102006011922 A DE 102006011922A DE 102006011922 A DE102006011922 A DE 102006011922A DE 102006011922 A1 DE102006011922 A1 DE 102006011922A1
Authority
DE
Germany
Prior art keywords
vitamin
use according
magnesium
blueberry extract
dosage unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102006011922A
Other languages
German (de)
English (en)
Inventor
Uwe Stoldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE102006011922A priority Critical patent/DE102006011922A1/de
Priority to JP2008558724A priority patent/JP2009529559A/ja
Priority to PCT/EP2007/002294 priority patent/WO2007104566A1/de
Priority to US12/282,691 priority patent/US20090220592A1/en
Priority to CA002646528A priority patent/CA2646528A1/en
Priority to EP07711962A priority patent/EP1993578A1/de
Priority to AU2007224668A priority patent/AU2007224668A1/en
Priority to EA200801890A priority patent/EA013457B1/ru
Publication of DE102006011922A1 publication Critical patent/DE102006011922A1/de
Priority to IL194066A priority patent/IL194066A0/en
Priority to US13/188,180 priority patent/US20110280972A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE102006011922A 2006-03-15 2006-03-15 Mittel zur Behandlung von Tinnitus Withdrawn DE102006011922A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE102006011922A DE102006011922A1 (de) 2006-03-15 2006-03-15 Mittel zur Behandlung von Tinnitus
EP07711962A EP1993578A1 (de) 2006-03-15 2007-03-15 Mittel zur behandlung von tinnitus
PCT/EP2007/002294 WO2007104566A1 (de) 2006-03-15 2007-03-15 Mittel zur behandlung von tinnitus
US12/282,691 US20090220592A1 (en) 2006-03-15 2007-03-15 Preparation for the treatment of tinnitus
CA002646528A CA2646528A1 (en) 2006-03-15 2007-03-15 Substance for the treatment of tinnitus
JP2008558724A JP2009529559A (ja) 2006-03-15 2007-03-15 耳鳴り治療用製剤
AU2007224668A AU2007224668A1 (en) 2006-03-15 2007-03-15 Substance for the treatment of tinnitus
EA200801890A EA013457B1 (ru) 2006-03-15 2007-03-15 Средство для лечения шума в ушах
IL194066A IL194066A0 (en) 2006-03-15 2008-09-14 Therapeutic composition for treatment of tinnitus
US13/188,180 US20110280972A1 (en) 2006-03-15 2011-07-21 Preparation for the treatment of tinnitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006011922A DE102006011922A1 (de) 2006-03-15 2006-03-15 Mittel zur Behandlung von Tinnitus

Publications (1)

Publication Number Publication Date
DE102006011922A1 true DE102006011922A1 (de) 2007-09-20

Family

ID=38229816

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102006011922A Withdrawn DE102006011922A1 (de) 2006-03-15 2006-03-15 Mittel zur Behandlung von Tinnitus

Country Status (9)

Country Link
US (2) US20090220592A1 (https=)
EP (1) EP1993578A1 (https=)
JP (1) JP2009529559A (https=)
AU (1) AU2007224668A1 (https=)
CA (1) CA2646528A1 (https=)
DE (1) DE102006011922A1 (https=)
EA (1) EA013457B1 (https=)
IL (1) IL194066A0 (https=)
WO (1) WO2007104566A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3768095A4 (en) * 2018-03-23 2021-12-29 Vanessa Research, Inc. Compositions and methods for treating diarrheal diseases

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201010691A (en) * 2008-06-12 2010-03-16 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
KR102175201B1 (ko) * 2019-09-06 2020-11-06 (주)아이엠디팜 빌베리 추출물을 유효성분으로 함유하는 감각신경성 난청 예방 또는 치료용 조성물
EP4299059A1 (en) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Composition for the treatment of tinnitus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005092330A1 (de) * 2004-03-24 2005-10-06 Aiones The Brainpower Company Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6524619B2 (en) * 2000-01-27 2003-02-25 Chronorx, Inc. Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus
JP2002308752A (ja) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd 皮膚外用剤
DE202004004618U1 (de) * 2004-03-24 2004-05-19 Aiones The Brainpower Company Blaubeerextrakt
JP2005306882A (ja) * 2005-06-08 2005-11-04 Alan Smith Richard 感情的不安定の治療のための医薬の製造に有用な組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005092330A1 (de) * 2004-03-24 2005-10-06 Aiones The Brainpower Company Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Sertac Yetiser et al.: The role of zinc in mana- gement of tinnitus. Auris, Larynx 29 (2002), S. 329-333, ISSN: 0385-8146
Sertac Yetiser et al.: The role of zinc in management of tinnitus. Auris, Larynx 29 (2002), S. 329-333, ISSN: 0385-8146 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3768095A4 (en) * 2018-03-23 2021-12-29 Vanessa Research, Inc. Compositions and methods for treating diarrheal diseases

Also Published As

Publication number Publication date
US20090220592A1 (en) 2009-09-03
IL194066A0 (en) 2009-09-22
AU2007224668A1 (en) 2007-09-20
EP1993578A1 (de) 2008-11-26
JP2009529559A (ja) 2009-08-20
EA200801890A1 (ru) 2009-04-28
CA2646528A1 (en) 2007-09-20
EA013457B1 (ru) 2010-04-30
WO2007104566A1 (de) 2007-09-20
US20110280972A1 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
DE502007010071C5 (de) Verwendung einer zusammensetzung aus mineralstoffen und gegebenenfalls acetogenen und/oder butyrogenen bakterien zur vermeidung oder reduzierung von gasbildung im dickdarm eines säugetiers und dadurch bedingter abdominaler beschwerden
US8557310B2 (en) Composition to retard the onset of symptoms of alzheimer's disease
DE69821524T2 (de) Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln
RS59141B1 (sr) Formulacija za lečenje ibs
WO2007104566A1 (de) Mittel zur behandlung von tinnitus
EP1886690B1 (de) Pharmazeutische Zusammensetzung zur Anwendung bei Nahrungsmittelunverträglichkeiten
DE102020134587B4 (de) 1,8-Cineol enthaltende Zusammensetzung für die therapeutische Verwendung
EP1799204A1 (de) Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung
IT201800006566A1 (it) Composizione per prevenire e trattare disordini uditivi e vestibolari
EP1609466B1 (de) Pharmazeutische Zusammensetzung, Verwendung dieser pharmazeutischen Zusammensetzung zur Herstellung eines Medikaments und/oder eines Nahrungsergänzungmittels zur Behandlung von Übergewicht und/oder Symptomen, die mit Übergewicht einhergehen, beim Menschen oder Säugetier, sowie Verfahren zur Herstellung dieser pharmazeutischen Zusammensetzung
US20090274780A1 (en) Menopause treatment composition and regimen
US6923967B1 (en) Treatment of dyspepsia
EP2688577B1 (de) Zusammensetzung zur anwendung bei verdauungsbeschwerden
DE202004006157U1 (de) Arzneimittel bzw. Nahrungsergänzungsmittel
WO2005092330A1 (de) Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe
DE69821970T2 (de) Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE
DE202007008818U1 (de) Zusammensetzung zur Behandlung von Infekten
CN104147146A (zh) 一种促进排铅的药物组合物及其制备方法和用途
DE202006012340U1 (de) Pharmazeutische Zusammensetzung, insbesondere zur Anwendung bei Nahrungsmittelunverträglichkeiten
DE202014005450U1 (de) Lactosefreies Arzneimittel
DE10053155A1 (de) Verwendung eines Multivitaminpräparats zur Behandlung der Schuppenflechte
DE102023126545A1 (de) Mehrphasen-Tablette mit schlaffördernder Wirkung
Figurska The role of resveratrol in inhibiting the development and progression of oxidative stress-induced retinal diseases
AT17461U1 (de) Nahrungsergänzungsmittel mit Maquibeerenextrakt
Tuso The herbal medicine pharmacy: what Kaiser Permanente providers need to know

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
R002 Refusal decision in examination/registration proceedings
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20131001